Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Medicines regulation

Superintendent and responsible pharmacist proposals delayed

The Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board has said that plans to introduce draft legislation to parliament in December 2018 are now being pushed back to March 2019.

Ken Karrold, chair of the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board

Source: Courtesy of Ken Jarrold

Ken Jarrold, chair of the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board, said “the board is giving full consideration” to the responses it received during the consultation

Proposals to clarify the roles of superintendent and responsible pharmacists have been delayed after concerns were expressed about the plans during the consultation process.

The Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board, which put together the proposals, has said that plans to introduce draft legislation to parliament in December 2018, which would be needed to bring the proposals into force, are now scheduled to happen in March 2019 instead.

The delay means that a planned extension of new legal defences for inadvertent prescribing errors to include hospital and other pharmacists will also be pushed back.

The board said that responses to the consultation “raised areas that require further consideration and clarification for stakeholders”.

Several concerns were expressed in responses to the consultation, which closed in September 2018, including that the proposed changes could see a single pharmacist made remotely responsible for more than one pharmacy.

In a statement, Ken Jarrold, chair of the board, said: “It was good to see a high level of engagement in responding to the consultation. The board is giving full consideration to what we heard and there is still work left to do to make sure we have got it right.

“I look forward to working closely with the board over the next few months to ensure the proposed legislation appropriately improves safety for users of pharmacy services, including through extending the defences for dispensing errors, and advances the innovation and developments of pharmacy practice.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205677

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Ken Karrold, chair of the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.